21242589

Source:http://linkedlifedata.com/resource/pubmed/id/21242589

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0205179, umls-concept:C0206657, umls-concept:C0332120, umls-concept:C0439851, umls-concept:C1176020, umls-concept:C1280500, umls-concept:C1552596, umls-concept:C1947931
pubmed:issue	7
pubmed:dateCreated	2011-6-27
pubmed:abstractText	The purpose of this study was to confirm sunitinib activity in alveolar soft part sarcoma (ASPS) and to report on new insights into the molecular bases thereof.
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/9007735
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Antineoplastic Agents, http://linkedlifedata.com/resource/pubmed/chemical/Indoles, http://linkedlifedata.com/resource/pubmed/chemical/Proto-Oncogene Proteins c-ret, http://linkedlifedata.com/resource/pubmed/chemical/Pyrroles, http://linkedlifedata.com/resource/pubmed/chemical/RET protein, human, http://linkedlifedata.com/resource/pubmed/chemical/Receptor, Platelet-Derived Growth..., http://linkedlifedata.com/resource/pubmed/chemical/Vascular Endothelial Growth Factor..., http://linkedlifedata.com/resource/pubmed/chemical/sunitinib
pubmed:status	MEDLINE
pubmed:month	Jul
pubmed:issn	1569-8041
pubmed:author	pubmed-author:BozykM EME, pubmed-author:BozziFF, pubmed-author:CasaliP GPG, pubmed-author:CassinelliGG, pubmed-author:ConciMM, pubmed-author:GronchiAA, pubmed-author:MorosoMM, pubmed-author:NegriTT, pubmed-author:PalassiniEE, pubmed-author:PilottiSS, pubmed-author:StacchiottiSS, pubmed-author:ZaffaroniNN
pubmed:issnType	Electronic
pubmed:volume	22
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	1682-90
pubmed:meshHeading	pubmed-meshheading:21242589-Adult, pubmed-meshheading:21242589-Antineoplastic Agents, pubmed-meshheading:21242589-Blotting, Western, pubmed-meshheading:21242589-Cell Proliferation, pubmed-meshheading:21242589-Female, pubmed-meshheading:21242589-Flow Cytometry, pubmed-meshheading:21242589-Fluorescent Antibody Technique, pubmed-meshheading:21242589-Follow-Up Studies, pubmed-meshheading:21242589-Humans, pubmed-meshheading:21242589-Immunoenzyme Techniques, pubmed-meshheading:21242589-Immunoprecipitation, pubmed-meshheading:21242589-In Situ Hybridization, Fluorescence, pubmed-meshheading:21242589-Indoles, pubmed-meshheading:21242589-Male, pubmed-meshheading:21242589-Middle Aged, pubmed-meshheading:21242589-Proto-Oncogene Proteins c-ret, pubmed-meshheading:21242589-Pyrroles, pubmed-meshheading:21242589-Receptor, Platelet-Derived Growth Factor beta, pubmed-meshheading:21242589-Retrospective Studies, pubmed-meshheading:21242589-Sarcoma, Alveolar Soft Part, pubmed-meshheading:21242589-Survival Rate, pubmed-meshheading:21242589-Treatment Outcome, pubmed-meshheading:21242589-Vascular Endothelial Growth Factor Receptor-2, pubmed-meshheading:21242589-Young Adult
pubmed:year	2011
pubmed:articleTitle	Sunitinib in advanced alveolar soft part sarcoma: evidence of a direct antitumor effect.
pubmed:affiliation	Department of Cancer Medicine, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy. silvia.stacchiotti@istitutotumori.mi.it
pubmed:publicationType	Journal Article, Research Support, Non-U.S. Gov't